Ann: Atomo & Access Bio enter North American COVID-19 partnership, page-160

Its a very easy process that doesn’t require any training. Placed the sample on the test strip and then place it into the reader. As for sensitivity it’s better than the current gold-based diagnostics.

"The development of this new platform marks a critical step in our collective journey to halt the spread of COVID-19," said Derek Thomson, CEO of xxxxxxxxx. "By leveraging many years of expert insight in the form of our AnteoBind europium nanoparticle technology and applying it to this unique challenge, we’re enabling detection of the lower viral particle levels seen in earlier stages of COVID-19 infection – levels which aren’t detectable with current gold-based diagnostics. As a result, we’re opening the possibility for better clinical decision-making and earlier direction of patients into quarantine to curtail disease spread."